Annabell Leske 26th Lorne Cancer Conference 2014

Abstracts this author is presenting:

• BL-011256 is a novel VEGFR3 selective inhibitor, which suppresses tumour lymphatics and lymph node metastasis in an animal model of melanoma — Poster Session 1